bharatbiotech
-
Covid-19
Bharat Biotech’s nasal vax gets nod for emergency use
Hyderabad, Sept 6 (UNI): Bharat Biotech International Limited (BBIL), a global leader in vaccine innovation and developer of vaccines for…
Read More » -
Covid-19
Covaxin, Covishield receive regulator nod for conditional market authorisation
New Delhi, Jan 27 (UNI): Two Covid-19 vaccines, Covaxin by Bharat Biotech and Covishield by the Serum Institute of India,…
Read More » -
Covid-19
Covaxin booster dose neutralises Omicron & Delta variants
New Delhi, Jan 12: Bharat Biotech said on Wednesday that Covaxin has the potential to neutralise SARS-CoV-2 variants, including Omicron.…
Read More » -
Covid-19
Violations in Pfizer/BioNTech vaccine studies not casting doubt on safety: EMA
Amsterdam, Nov 4 (UNI/Sputnik): Information about violations allegedly recorded during studies of the Pfizer/BioNTech vaccine against Covid-19 do not call…
Read More » -
Covid-19
WHO authorises Bharat Biotech’s Covaxin for emergency use
Shillong, Nov 4: Bharat Biotech, a global leader in vaccine development and innovation, has announced that Covaxin, India’s first indigenous…
Read More »